stockrowBruker Corporation (BRKR) vs Haemonetics Corporation (HAE)
- Bruker Corporation BRKR 61.43 +5.80%
- Haemonetics Corporation HAE 119.66 −3.59%
Bruker Corporation and Haemonetics Corporation are both Medical Devices companies. Bruker Corporation is the larger, with a market value of $8.9B against $5.7B — 1.6× the size. Bruker Corporation has negative trailing earnings, so its P/E is not meaningful; Haemonetics Corporation trades at 54.5×. Haemonetics Corporation grew revenue faster over the last twelve months: 4.11% against 2.16%. Haemonetics Corporation has the higher net margin (7.52% vs −4.76%) and the higher return on invested capital (6.31% vs −1.12%). Across the 21 metrics below, Haemonetics Corporation leads on 16 and Bruker Corporation on 5.
Valuation
Profitability
| Metric | BRKR | HAE | Medical Devices median |
|---|---|---|---|
| Gross margin | 47.66% | 59.63% | 57.76% |
| Operating margin | (1.99%) | 12.80% | (15.07%) |
| Net margin | (4.76%) | 7.52% | (14.45%) |
| Free cash flow margin | 6.97% | 24.95% | (3.88%) |
| Return on equity | (7.04%) | 11.89% | (10.35%) |
| Return on assets | (2.73%) | 4.28% | (17.26%) |
| Return on invested capital | (1.12%) | 6.31% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack